SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001437749-13-006615
Filing Date
2013-05-24
Accepted
2013-05-23 19:25:10
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A pdli_10qa-063012.htm 10-Q/A 47254
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 1041536
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 5080
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 5343
5 logo.jpg GRAPHIC 23080
6 a1.jpg GRAPHIC 25384
7 a2.jpg GRAPHIC 51080
8 a3.jpg GRAPHIC 71247
9 a4.jpg GRAPHIC 69987
  Complete submission text file 0001437749-13-006615.txt   1432595
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-19756 | Film No.: 13869937
SIC: 2836 Biological Products, (No Diagnostic Substances)